🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 29668H104
- Market Cap
- Small Cap
Business: ESSA Pharma, Inc. is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with focus on advanced prostate cancer. ESSA is developing drugs that selectively block the N-terminal domain of the androgen receptor (AR). The AR is required for the growth and survival of most prostate cancer; therefore, the AR N-terminal domain is an ideal target for next-generation hormone therapy.
Company Contact
- CEO
- David R. Parkinson
- CFO
- David Wood
- Headquarters
- Suite 720, 999 West Broadway, Vancouver, BC V5Z 1K5
- Phone
- 778-331-0962
- Investor Relations
- David Wood · 778-331-0962 · dwood@essapharma.com